Guardant Health
GH
#3559
Rank
NZ$4.98 B
Marketcap
$40.55
Share price
-1.18%
Change (1 day)
-12.26%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : NZ$2.60 B

According to Guardant Health 's latest financial reports the company's total liabilities are NZ$2.60 B. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Guardant Health - Total liabilities on balance sheet (from 2017 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$2.57 B5.44%
2022-12-31NZ$2.44 B7.2%
2021-12-31NZ$2.27 B78.76%
2020-12-31NZ$1.27 B650.23%
2019-12-31NZ$0.16 B82.46%
2018-12-31NZ$93.06 M92.51%
2017-12-31NZ$48.34 M-9.18%
2016-12-31NZ$53.22 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$1.09 B-57.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.27 B-12.80%๐Ÿ‡บ๐Ÿ‡ธ USA